GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients

Abstract

Age at GHD diagnosis was a significant predictor for many outcomes at baseline, but disease onset did not appear as an independent predictor concerning changes after 3 years of GH treatment. The results suggest that GH replacement during the transition period should be considered independently of the onset of the deficiency.